{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:49:48Z","timestamp":1761871788668,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.clml.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T18:23:01Z","timestamp":1626718981000},"page":"e938-e945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases"],"prefix":"10.1016","volume":"21","author":[{"given":"Bella V.","family":"Biderman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina B.","family":"Likold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana Yu.","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene A.","family":"Nikitin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darya A.","family":"Koroleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeniy E.","family":"Zvonkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyubov S.","family":"Al-Radi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunan L.","family":"Julhakyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey B.","family":"Sudarikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.07.005_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4939-9151-8_7","article-title":"Stereotyped B cell receptor immunoglobulins in B cell lymphomas","volume":"1956","author":"Agathangelidis","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.clml.2021.07.005_bib0002","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clml.2021.07.005_bib0003","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0004","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"941","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0005","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/leu.2017.125","article-title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations","volume":"31","author":"Rosenquist","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.07.005_bib0006","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2002-11-3485","article-title":"Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope","volume":"101","author":"Tobin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0007","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","article-title":"Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia","volume":"104","author":"Tobin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0008","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1182\/blood-2004-03-0818","article-title":"Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins","volume":"104","author":"2nd","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0009","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20040544","article-title":"Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen inpromoting chronic lymphocytic leukemia","volume":"200","author":"Messmer","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.clml.2021.07.005_bib0010","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2005-04-1511","article-title":"Immunoglobulin light chain repertoire in chronic lymphocytic leukemia","volume":"106","author":"Stamatopoulos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hoc.2012.12.001","article-title":"The significance of stereotyped B-cell receptors in chronic lymphocytic leukemia","volume":"27","author":"Darzentas","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.clml.2021.07.005_bib0012","article-title":"Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL","author":"Agathangelidis","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.clml.2021.07.005_bib0013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2119\/2005-00001.Stamatopoulos","article-title":"Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma","volume":"10","author":"Stamatopoulos","year":"2004","journal-title":"Mol Med"},{"issue":"2","key":"10.1016\/j.clml.2021.07.005_bib0014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11864-014-0285-5","article-title":"Update on the biology and treatment options for hairy cell leukemia","volume":"15","author":"Jain","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.clml.2021.07.005_bib0015","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2021.07.005_bib0016","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"15","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.clml.2021.07.005_bib0017","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"16","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.clml.2021.07.005_bib0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0161-5890(92)90100-C","article-title":"Use of family specific leader region primers for PCR amplification of the human heavy chain variable region repertoire","volume":"29","author":"Campbell","year":"1992","journal-title":"Mol Immunol"},{"key":"10.1016\/j.clml.2021.07.005_bib0019","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.07.005_bib0020","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clml.2021.07.005_bib0021","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-d-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clml.2021.07.005_bib0022","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/bioinformatics\/btv456","article-title":"ARResT\/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy","volume":"31","author":"Bystry","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clml.2021.07.005_bib0023","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0024","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","article-title":"Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases","volume":"118","author":"Hadzidimitriou","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0025","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","article-title":"Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications","volume":"26","author":"Bikos","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.07.005_bib0026","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.2012.09163.x","article-title":"The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma","volume":"158","author":"Hockley","year":"2012","journal-title":"Br. J. Haematol"},{"key":"10.1016\/j.clml.2021.07.005_bib0028","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2141.2010.08347.x","article-title":"Immunogenetics features and genomic lesions in splenic marginal zone lymphoma","volume":"151","author":"Rinaldi","year":"2010","journal-title":"Br J Haematol."},{"key":"10.1016\/j.clml.2021.07.005_bib0029","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1182\/blood-2009-03-212449","article-title":"Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior","volume":"114","author":"Forconi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3324\/haematol.2018.195032","article-title":"Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia","volume":"104","author":"Baliakas","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.07.005_bib0031","doi-asserted-by":"crossref","first-page":"20520","DOI":"10.18632\/oncotarget.7819","article-title":"Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia","volume":"7","author":"Marinelli1","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2021.07.005_bib0032","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3324\/haematol.2016.157552","article-title":"Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications","volume":"102","author":"Wu","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.07.005_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10428190601043310","article-title":"Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia","volume":"48","author":"Farsangi","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.07.005_bib0034","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2020-140663","article-title":"Genetic lesions in Russian CLL patients with the most common stereotyped antigen receptors","author":"Biderman","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0035","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ajpath.2017.02.017","article-title":"Numerous ontogenetic roads to mantle cell lymphoma","volume":"187","author":"Pouliou","year":"2017","journal-title":"Am J Pathol."},{"key":"10.1016\/j.clml.2021.07.005_bib0036","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11864-014-0285-5","article-title":"Update on the biology and treatment options for hairy cell leukemia","volume":"15","author":"Jain","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.clml.2021.07.005_bib0037","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2011-09-379339","article-title":"Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation","volume":"119","author":"Xi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.07.005_bib0038","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S2352-3026(14)00005-2","article-title":"Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study","volume":"1","author":"Baliakas","year":"2014","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clml.2021.07.005_bib0039","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","article-title":"Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma","volume":"95","author":"Zibellini","year":"2010","journal-title":"Haematologica"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021002755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021002755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:38:16Z","timestamp":1761871096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021002755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2152265021002755"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.07.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}